ESH Video


July 02 - July 04, 2010 - Lisbon, Portugal
Chairs :


The goals of this conference are to define ageing in biological terms, to illustrate the unique aspects of treatment related to ageing, and to practically address treatment issues in the different types of haematological malignancies, including treatments like allogeneic stem cell transplantation.


Friday, July 2, 2010

09h00 Welcome
09h15 - 10h00 Opening conference: A panorama on ageing: anaemia in the elderly L. Balducci (Tampa)

I. Ageing: physiology and pathophysiology

10h00 - 10h30 Epidemiology of ageing in Europe and in the world:
clinical and social consequences
A.J. Cruz-Jentoft (Madrid)
10h30 - 11h00 Biology of ageing

I. Irminger-Finger (Geneva)

11h00 - 11h30 Coffee break
11h30 - 12h00 The ageing bone marrow C. Franceschi (Bologna)
12h00 - 14h00 Lunch

II. Clinical evaluation of older persons

14h00 - 14h30 Life expectancy and frailty M. Rainfray (Bordeaux)
14h30 - 15h00 Comorbidity, polymorbidity and polypharmacy G. Gambassi (Rome)
15h00 - 15h30 Functional assessment of the elderly M. Barbagallo (Palermo)
15h30 - 16h00 Pharmacology of ageing C. Léger-Falandry (Lyon)
16h00 - 16h30 Coffee break

III. Myelotoxicity of chemotherapy in the elderly person

16h30 - 17h00 Ageing and marrow depression L. Balducci (Tampa)
17h00 - 17h20 Infections in elderly patients with haematological malignancies L. Balducci (Tampa)
17h20 - 18h30 Manned Poster Session
19h30 Welcome cocktail


Saturday, July 3, 2010

IV. MDS and acute leukaemia in the elderly

08h30 - 09h00 MDS: a disease of very elderly patients R. Stauder (Innsbruck)
09h00 - 09h30 Treatment of anaemia of lower risk MDS in the elderly:
transfuse or prevent anaemia?
P. Fenaux (Paris)
09h30 - 10h00 Hypomethylating agents and chemotherapy in higher risk MDS in the elderly: up to what age?
P. Fenaux (Paris)
10h00 - 10h30 Quality of life and functional tests in elderly patients with MDS:
an important part of treatment endpoints
O. Beyne-Rauzi (Toulouse)
10h30 - 11h00 Coffee break
11h00 - 11h30 The role of iron chelation therapy in elderly patients with MDS C. Rose (Lille)
11h30 - 12h00 Biology of AML in the elderly A. Renneville (Lille)
12h00 - 12h30 Management of AML in the elderly C. Gardin (Paris)
12h30 - 13h00 Biology and treatment of ALL in the elderly A. Delannoy (Brussels)
13h00 - 14h30 Lunch

V. Myeloma and monoclonal gammopathies diagnosis and prognosis

14h30 - 15h00 Monoclonal gammopathies and multiple myeloma:
diagnostic criteria and prognostic factors
J. Blade (Barcelona)
15h00 - 15h30 Are current concepts in the treatment of multiple myeloma useful in elderly patients? J.-L. Harousseau (Nantes)
15h30 - 16h00 Treatment of multiple myeloma in the elderly T. Facon (Lille)
16h00 - 16h30 Prophylaxis and management of toxicities induced by novel agents M. Delforge (Belgium)
16h30 - 17h00 Coffee Break
17h00 - 17h30 Special lecture: The caregiver of the older aged person L. Balducci (Tampa)
17h30 - 18h00 Helping the patient: how to focus on the real problems after cancer treatment F. Pein (Nantes)
18h00 - 19h00 Manned Poster Session 2
20h00 Dinner

Sunday, July 4, 2010

VI. Aggressive lymphoma in the elderly

08h30 - 09h00 Diffuse large B-cell lymphoma in the elderly pending
09h00 - 09h30 Hodgkin’s disease in the elderly pending

VII. Chronic lymphoproliferative disorders in the elderly

09h30 - 10h00 Indolent lymphoma in the elderly

C. Buske (Ulm)

10h00 - 10h30 Treatment of CLL in the elderly V. Levy (Paris)
10h30 - 11h00 Coffee break

VIII. Chronic myeloproliferative neoplasms in the elderly

11h00 - 11h30 CML in the elderly P. Rousselot (Versailles)
12h00 - 12h30 Other MPN J.J. Kiladjian (Paris)

IV. Allogeneic stem cell transplantation in elderly patients: is it feasible and effective?

12h30 - 13h00 J. Apperley (London)
Meeting Closure

Abstract submission




Corporate partners